Elliot Wiesenfeld

Elliot Wiesenfeld practices at Englewood Hospital in Englewood, New Jersey, part of RWJBarnabas Health.

Elliot Wiesenfeld's NPI, 1194118794, was assigned on March 6, 2015. Elliot Wiesenfeld graduated from McGaw Medical Center of Northwestern University in 2017. Elliot Wiesenfeld holds New Jersey license 25MA11791000.

Elliot Wiesenfeld's primary practice is Englewood Hospital, at 350 Engle St, Englewood, NJ 07631 in Bergen County. The practice phone is (201) 894-3000.

Elliot Wiesenfeld's primary practice is Englewood Hospital in Englewood, New Jersey, part of RWJBarnabas Health. The medical group on file is Medical Associates at Englewood. Dmand AI also links Elliot Wiesenfeld to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Elliot Wiesenfeld practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Elliot Wiesenfeld's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Elliot Wiesenfeld is licensed in New Jersey.

CMS data shows 2,468 Medicare services from Elliot Wiesenfeld across 22 procedure codes in 2024, for 824 Medicare patients. Medicare paid $181,688 for them.

CMS counts 824 Medicare patients who saw Elliot Wiesenfeld in 2024. The largest group is 75 to 84, with 311 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Elliot Wiesenfeld's median patient age at 71, with 49% women.

In 2024, Elliot Wiesenfeld wrote 319 Medicare Part D claims for 92 patients. 80% of them were for generic drugs. CMS names the drug for 198 of them, across 9 drugs with 11 or more claims each, at $49,396 in total drug cost. In 2023, CMS named 243 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Elliot Wiesenfeld for performance year 2024, reported through an alternative payment model (APM). Elliot Wiesenfeld accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Elliot Wiesenfeld, published from 2016 to 2025. Elliot Wiesenfeld's most frequent co-authors are Ulrich Peter Jorde, MD, Snehal R. Patel, MD and Jooyoung Julia Shin, MD.

CMS Open Payments shows 41 general payments to Elliot Wiesenfeld from 19 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $266.

Elliot Wiesenfeld graduated from McGaw Medical Center of Northwestern University in 2017.